surpass cvot tirzepatide results Effects of on adjudicated cardiovascular events in 💡 New insight in diabetes

Our findings, combined with existing evidence, suggest that semaglutide and perhaps other GLP1-RAs should be reconceptualized as disease-modifying treatments rather than solely medications for glycaemic control or weight loss, concluded the authors

Who May Be a Better Fit for Tirzepatide

Dulaglutide significantly reduced the risk of this primary composite outcome by 12% compared to placebo (p=0.026)

Hepatology 51:445453 Torres DM, Jones FJ, Shaw JC et al (2011) Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial

The genetic context upstream of any brand PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, including the Tirzepatide Injection

Both doses of 10 mg and 25 mg had similar hazard ratios for cardiovascular outcomes